EP Patent

EP2448572A1 — Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation

Assigned to INO Therapeutics LLC · Expires 2012-05-09 · 14y expired

What this patent protects

The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

USPTO Abstract

The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

Drugs covered by this patent

Patent Metadata

Patent number
EP2448572A1
Jurisdiction
EP
Classification
—
Expires
2012-05-09
Drug substance claim
No
Drug product claim
No
Assignee
INO Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.